Turning Point Therapeutics, Inc.

ORBIMED ADVISORS LLC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

2,012,250

Value ($000)

151,422

Weight

2.8%

2019 Q4 - 2022 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	151,422	2.8%	2,012,250	6/30/2022
2022 Q1	5/16/2022	54,209	0.9%	2,018,950	3/31/2022
2021 Q4	2/14/2022	100,478	1.3%	2,106,450	12/31/2021
2021 Q3	11/15/2021	156,863	1.8%	2,361,327	9/30/2021
2021 Q2	8/16/2021	184,231	1.9%	2,361,327	6/30/2021
2021 Q1	5/17/2021	223,358	2.2%	2,361,327	3/31/2021
2020 Q4	2/16/2021	334,518	2.9%	2,745,327	12/31/2020
2020 Q3	11/16/2020	239,832	3.0%	2,745,327	9/30/2020
2020 Q2	8/14/2020	177,321	2.5%	2,745,327	6/30/2020
2020 Q1	5/15/2020	122,606	2.1%	2,745,327	3/31/2020
2019 Q4	2/14/2020	171,006	2.4%	2,745,327	12/31/2019